AI-driven QbD: Advancing predictive, data-driven pharma formulation development using artificial neural networks

Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy